DK128490D0 - Renset gensekvens, som koder for protein ia, ib eller begge fra neisseria gonorrhoeae, rekombinantvektorer og organismer indeholdende sekvenser, dens fremstilling og anvendelse, neisseria-stamme og dennes paavisning - Google Patents
Renset gensekvens, som koder for protein ia, ib eller begge fra neisseria gonorrhoeae, rekombinantvektorer og organismer indeholdende sekvenser, dens fremstilling og anvendelse, neisseria-stamme og dennes paavisningInfo
- Publication number
- DK128490D0 DK128490D0 DK128490A DK128490A DK128490D0 DK 128490 D0 DK128490 D0 DK 128490D0 DK 128490 A DK128490 A DK 128490A DK 128490 A DK128490 A DK 128490A DK 128490 D0 DK128490 D0 DK 128490D0
- Authority
- DK
- Denmark
- Prior art keywords
- neisseria
- trible
- paving
- cleaned
- requirements
- Prior art date
Links
- 241000588653 Neisseria Species 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000013598 vector Substances 0.000 title abstract 2
- 241000588652 Neisseria gonorrhoeae Species 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 101710167885 Major outer membrane protein P.IB Proteins 0.000 abstract 3
- 206010018612 Gonorrhoea Diseases 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Plant Pathology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12472787A | 1987-11-24 | 1987-11-24 | |
| US12472787 | 1987-11-24 | ||
| US24275888A | 1988-09-09 | 1988-09-09 | |
| US24275888 | 1988-09-09 | ||
| PCT/US1988/004225 WO1989004873A1 (en) | 1987-11-24 | 1988-11-23 | Production of gonorrheal pi proteins and vaccines |
| US8804225 | 1988-11-23 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK128490D0 true DK128490D0 (da) | 1990-05-23 |
| DK128490A DK128490A (da) | 1990-07-06 |
| DK175831B1 DK175831B1 (da) | 2005-03-14 |
Family
ID=26822891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK199001284A DK175831B1 (da) | 1987-11-24 | 1990-05-23 | Neisseria gonorrhoeae-relaterede nucleinsyrer, rekombinantvektorer, værtsorgaismer, encellede organismer, polypeptidfremstillingsmetoder, polypeptidsammensætninger, vaccinepræparater, DNA-sonder, påvisningsmetoder og diagnostiske prövesæt, ......... |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US5736361A (da) |
| EP (2) | EP0395706B1 (da) |
| JP (2) | JP2803058B2 (da) |
| KR (1) | KR970011309B1 (da) |
| AT (1) | ATE169958T1 (da) |
| AU (1) | AU629807B2 (da) |
| CA (1) | CA1340506C (da) |
| DE (1) | DE3856240T2 (da) |
| DK (1) | DK175831B1 (da) |
| FI (1) | FI102189B1 (da) |
| NO (1) | NO302622B1 (da) |
| WO (1) | WO1989004873A1 (da) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1340506C (en) * | 1987-11-24 | 1999-04-20 | Nicholas H. Carbonetti | Production of gonorrheal pi proteins and vaccines |
| US7118757B1 (en) * | 1988-12-19 | 2006-10-10 | Wyeth Holdings Corporation | Meningococcal class 1 outer-membrane protein vaccine |
| ES2127217T3 (es) * | 1991-03-14 | 1999-04-16 | Imclone Systems Inc | Epitopos de porina hibridos de recombinacion. |
| EP0717774A1 (en) * | 1993-07-30 | 1996-06-26 | University Of North Carolina At Chapel Hill | Production of gonorrheal pi proteins and vaccines in e. coli and salmonella |
| US7252828B2 (en) | 1998-07-15 | 2007-08-07 | The Brigham And Women's Hospital, Inc. | Polysaccharide vaccine for staphylococcal infections |
| CA2767116A1 (en) * | 1999-05-13 | 2000-11-23 | Wyeth Holdings Corporation | Adjuvant combination formulations |
| ATE435028T1 (de) * | 1999-09-30 | 2009-07-15 | Isis Innovation | Impfstoff gegen neisseria infektion |
| PT2270030E (pt) * | 2000-02-28 | 2012-07-24 | Novartis Vaccines & Diagnostic | Expressão heteróloga de proteínas de neisseria |
| IL155690A0 (en) * | 2000-11-10 | 2003-11-23 | Wyeth Corp | Adjuvant combination formulations |
| US7723087B2 (en) | 2002-11-12 | 2010-05-25 | The Brigham And Women's Hospital, Inc. | Nucleic acid molecules for enhanced production of a bacterial polysaccharide and methods of use thereof |
| WO2004043405A2 (en) | 2002-11-12 | 2004-05-27 | The Brigham And Women's Hospital, Inc. | Polysaccharide vaccine for staphylococcal infections |
| SI1745075T1 (sl) | 2004-04-21 | 2013-07-31 | The Brigham And Women's Hospital, Inc. | Poli-N-acetilglukozamin (PNAG/dPNAG) vezavni peptidi in postopki za njihovo uporabo |
| US7037698B2 (en) | 2004-05-19 | 2006-05-02 | Amano Enzyme Inc. | Pyrroloquinoline quinone-dependent glucose dehydrogenase |
| KR20110031393A (ko) | 2008-07-21 | 2011-03-25 | 더 브리검 앤드 우먼즈 하스피털, 인크. | 합성 베타-1,6 글루코사민 올리고당에 관한 방법 및 조성물 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4237224A (en) * | 1974-11-04 | 1980-12-02 | Board Of Trustees Of The Leland Stanford Jr. University | Process for producing biologically functional molecular chimeras |
| US4203971A (en) * | 1978-03-23 | 1980-05-20 | Government Of The United States | Neisseria gonorrhoeae vaccine |
| DE2814039C3 (de) * | 1978-03-31 | 1981-02-19 | Gesellschaft Fuer Biotechnologische Forschung Mbh (Gbf), 3300 Braunschweig | Verfahren zur Herstellung von Hybrid-Bakterien |
| US4351761A (en) * | 1978-05-15 | 1982-09-28 | Research Corporation | Purified antigen to test for Neisseria gonorrhoeae antibodies |
| US4220638A (en) * | 1978-10-12 | 1980-09-02 | Merck & Co., Inc. | Antigenic complex from N. Gonorrhoeae |
| US4288557A (en) * | 1978-10-12 | 1981-09-08 | Merck & Co., Inc. | Antigenic complex from N. gonorrhoeae |
| US4239749A (en) * | 1979-09-27 | 1980-12-16 | United States Of America | Neisseria gonorrhoeae vaccine |
| FI63596C (fi) * | 1981-10-16 | 1983-07-11 | Orion Yhtymae Oy | Mikrobdiagnostiskt foerfarande som grundar sig pao skiktshybridisering av nukleinsyror och vid foerfarandet anvaenda kombinationer av reagenser |
| WO1983003354A1 (en) * | 1982-03-30 | 1983-10-13 | Us Army | Neisseria gonorrhoeae vaccine |
| EP0178863A1 (en) * | 1984-10-15 | 1986-04-23 | Schering Corporation | Novel expression systems utilizing bacteriophage T7 promoters and gene sequences |
| US4681761A (en) * | 1985-10-24 | 1987-07-21 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University | Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine |
| US4786592A (en) * | 1986-06-18 | 1988-11-22 | Scripps Clinic And Research Foundation | Neisseria gonorrhoeae lectin useful as a vaccine and diagnostic marker and means for producing this lectin |
| CA1340506C (en) * | 1987-11-24 | 1999-04-20 | Nicholas H. Carbonetti | Production of gonorrheal pi proteins and vaccines |
-
1988
- 1988-11-22 CA CA000583787A patent/CA1340506C/en not_active Expired - Fee Related
- 1988-11-23 DE DE3856240T patent/DE3856240T2/de not_active Expired - Lifetime
- 1988-11-23 EP EP89900540A patent/EP0395706B1/en not_active Expired - Lifetime
- 1988-11-23 EP EP98101882A patent/EP0869133A1/en not_active Withdrawn
- 1988-11-23 AU AU27959/89A patent/AU629807B2/en not_active Expired
- 1988-11-23 WO PCT/US1988/004225 patent/WO1989004873A1/en active IP Right Grant
- 1988-11-23 AT AT89900540T patent/ATE169958T1/de not_active IP Right Cessation
- 1988-11-23 JP JP1500595A patent/JP2803058B2/ja not_active Expired - Lifetime
- 1988-11-23 KR KR1019890701369A patent/KR970011309B1/ko not_active IP Right Cessation
-
1990
- 1990-05-22 NO NO902251A patent/NO302622B1/no unknown
- 1990-05-23 FI FI902569A patent/FI102189B1/fi not_active IP Right Cessation
- 1990-05-23 DK DK199001284A patent/DK175831B1/da not_active IP Right Cessation
-
1992
- 1992-12-01 US US07/983,995 patent/US5736361A/en not_active Expired - Fee Related
-
1997
- 1997-11-06 US US08/965,085 patent/US6068992A/en not_active Expired - Fee Related
-
1998
- 1998-01-22 JP JP04415498A patent/JP3388171B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US5736361A (en) | 1998-04-07 |
| ATE169958T1 (de) | 1998-09-15 |
| US6068992A (en) | 2000-05-30 |
| EP0869133A1 (en) | 1998-10-07 |
| KR970011309B1 (ko) | 1997-07-09 |
| FI102189B (fi) | 1998-10-30 |
| NO302622B1 (no) | 1998-03-30 |
| JPH10234388A (ja) | 1998-09-08 |
| DK128490A (da) | 1990-07-06 |
| AU2795989A (en) | 1989-06-14 |
| DE3856240T2 (de) | 1999-05-06 |
| FI102189B1 (fi) | 1998-10-30 |
| FI902569A0 (fi) | 1990-05-23 |
| EP0395706A1 (en) | 1990-11-07 |
| WO1989004873A1 (en) | 1989-06-01 |
| KR890701750A (ko) | 1989-12-21 |
| NO902251D0 (no) | 1990-05-22 |
| NO902251L (no) | 1990-07-18 |
| JP3388171B2 (ja) | 2003-03-17 |
| DE3856240D1 (de) | 1998-09-24 |
| JP2803058B2 (ja) | 1998-09-24 |
| JPH03502881A (ja) | 1991-07-04 |
| CA1340506C (en) | 1999-04-20 |
| AU629807B2 (en) | 1992-10-15 |
| EP0395706B1 (en) | 1998-08-19 |
| EP0395706A4 (en) | 1991-11-13 |
| DK175831B1 (da) | 2005-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG19101A (en) | Process for preparing of expression of human proapolipoprotein A.1. | |
| DK128490D0 (da) | Renset gensekvens, som koder for protein ia, ib eller begge fra neisseria gonorrhoeae, rekombinantvektorer og organismer indeholdende sekvenser, dens fremstilling og anvendelse, neisseria-stamme og dennes paavisning | |
| RU95117238A (ru) | Нуклеиновая кислота, рекомбинантная плазмида, рекомбинантный вектор, белок, синтетический пептид, химерная молекула, иммуногенная композиция, антисыворотка или антитела | |
| NO910797L (no) | Dna-fragment som koder for et polypeptid med nitrilhydratase-aktivitet, en transformant inneholdende genet og en fremgangsmaate for fremstilling av amider ved bruk av transformanten. | |
| ATE338113T1 (de) | Transferrin-rezeptor gene von haemophilus | |
| ATE287954T1 (de) | Trägerprotein mit adjuvant aktivität, diese enthaltende immunogene komplexe, ihre herstellung,nukleotidsequenz und impfstoff | |
| NO177570B (no) | Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper | |
| DK595187A (da) | Minactivin og fremgangsmaade til fremstilling deraf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUP | Patent expired |